IL-23过去,现在和未来:促进IL-23科学和治疗的路线图
James G Krueger1, Kilian Eyerich2,3, Vijay K Kuchroo4
1Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, United States.
Frontiers in immunology
|April 30, 2024
概括
介素-23 (IL-23) 是免疫媒介性炎症性疾病 (IMID) 中的一个关键细胞因子. 向IL-23为牛皮和炎症性肠病等疾病提供了一个有希望的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 医学科学 医学科学 医学科学
背景情况:
- 介乐-23 (IL-23) 是IL-12家族中的一个关键细胞因子.
- 它在免疫媒介性炎症性疾病 (IMIDs) 中发挥着主要的调节作用.
- 受到IL-23影响的关键IMID包括牛皮,牛皮关节炎和炎症性肠病.
研究的目的:
- 审查IL-23.3的基本生物学.
- 检查IL-23信号在IMID中的作用.
- 评估IL-23抑制作为IMID治疗方法的疗效.
主要方法:
- 关于IL-23生物学及其在IMID中的作用的文献综述.
- 对IL-23信号通路的现有数据的分析.
- 对抗IL-23疗法的临床结果的检查.
主要成果:
- IL-23是几个IMIDs的发病过程中的中心调解者.
- 抑制IL-23已经证明在治疗这些疾病方面具有治疗效益.
- 了解IL-23生物学对于开发向疗法至关重要.
结论:
- IL-23是IMIDs的一个重要的治疗点.
- 需要进一步的研究来完善抗IL-23疗法,并确定患者子组.
- 针对IL-23驱动疾病的新型分子本体学可以改善患者的治疗结果.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


